Corrigendum re: "Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens" [Eur Urol 2018;73:462-8]

Affiliations

• ¹ Clínica Universidad de Navarra, Pamplona, Spain. Electronic address: jlgracia@unav.es.
• ² Gustave Roussy, Université Paris-Saclay, Département de Médecine, Villejuif, France.
• ³ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁴ Barts Cancer Institute, Queen Mary University of London, London, UK.
• ⁵ Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
• ⁶ Plymouth University, Peninsula Schools of Medicine and Dentistry, Plymouth University Hospitals NHS Trust, Devon, UK.
• ⁷ Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.
• ⁸ Urologische Klinik und Poliklinik, Technical University Munich, Munich, Germany.
• ⁹ Department of Urology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
• ¹⁰ Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
• ¹¹ Department of Oncology, Hôpital Foch, Suresnes, France.
• ¹² Hospital Universitario Ramón y Cajal, Madrid, Spain.
• ¹³ Genentech, Inc., South San Francisco, CA, USA.
• ¹⁴ Netherlands Cancer Institute, Amsterdam, The Netherlands.